Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 4/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21532347 | 0.96 | NPC1 (0.36) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL21532145 | 0.93 | NPC1 (0.35) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL21532509 | 0.92 | L3MBTL1 (0.36) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL21532154 | 0.91 | RAC2 (0.35) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL21532360 | 0.89 | IDO1 (0.37) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL21532409 | 0.89 | SMN1; SMN2 (0.36) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL21532147 | 0.89 | NPC1 (0.36) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL21532733 | 0.89 | IDO1 (0.37) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL15762187 | 0.89 | L3MBTL1 (0.40) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 | |
| SCHEMBL15762181 | 0.89 | L3MBTL1 (0.40) | NPC1RAB9ASMN1; SMN2DHODHL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11145825-B2 | Condensed cyclic compound and organic light-emitting device including i he same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-10-12 | — | — | US | disclosed |
| US-20190334095-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145825-B2 | Condensed cyclic compound and organic light-emitting device including i he same | CRY1, CCNT1, CCNA1 | NPC1 1879/4885RAB9A 1780/4885SMN1; SMN2 2430/4885 |
| US-20190334095-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, ARL1 | NPC1 2440/4885RAB9A 2046/4885SMN1; SMN2 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.